Background: Microscopic inflammation has significant prognostic value in ulcerative colitis (UC); however, its assessment is complex with high interobserver variability. We aimed to develop and validate an artificial intelligence (AI) Computer-Aided Diagnosis System to evaluate UC biopsies and predict prognosis. Methods: 535 digitalized biopsies (273 patients) were graded according to the PICaSSO Histologic Remission Index (PHRI), Robarts' (RHI), and Nancy Histological Index (NHI). A convolutional neural network classifier was trained to distinguish remission from activity on a subset of 118 biopsies, calibrated on 42 and tested on 375. The model was additionally tested to predict the corresponding endoscopic assessment and occurrence of flares at 12 months. The system output was compared with human assessment. Diagnostic performance was reported as sensitivity, specificity; prognostic prediction through Kaplan-Meier and hazard ratios of flares between active and remission groups. We externally validated the model in 154 biopsies (58 patients) with similar characteristics but more histologically active patients. Results: The system distinguished histological activity/remission with sensitivity and specificity of 89% and 85% (PHRI), 94% and 76% (RHI), and 89% and 79% (NHI). The model predicted the corresponding endoscopic remission/activity with 79% and 82% accuracy for UCEIS and PICaSSO, respectively. The hazard ratio for disease flare-up between histological activity/remission groups according to pathologist-assessed PHRI was 3.56, and 4.64 for AI-assessed PHRI. Both histology and outcome prediction were confirmed in the external validation cohort. Conclusion: We developed and validated an AI model that distinguishes histological remission/activity in biopsies of UC and predicts flare-ups. This can expedite, standardize and enhance histological assessment in practice and trials.

Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis / M. Iacucci, T.L. Parigi, R. Del Amor, P. Meseguer, G. Mandelli, A. Bozzola, A. Bazarova, P. Bhandari, R. Bisschops, S. Danese, G. De Hertogh, J.G. Ferraz, M. Goetz, E. Grisan, X. Gui, B. Hayee, R. Kiesslich, M. Lazarev, R. Panaccione, A. Parra-Blanco, L. Pastorelli, T. Rath, E.S. Røyset, G.E. Tontini, M. Vieth, D. Zardo, S. Ghosh, V. Naranjo, V. Villanacci. - In: GASTROENTEROLOGY. - ISSN 0016-5085. - (2023). [Epub ahead of print] [10.1053/j.gastro.2023.02.031]

Artificial Intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis

A. Bozzola;L. Pastorelli;G.E. Tontini;
2023

Abstract

Background: Microscopic inflammation has significant prognostic value in ulcerative colitis (UC); however, its assessment is complex with high interobserver variability. We aimed to develop and validate an artificial intelligence (AI) Computer-Aided Diagnosis System to evaluate UC biopsies and predict prognosis. Methods: 535 digitalized biopsies (273 patients) were graded according to the PICaSSO Histologic Remission Index (PHRI), Robarts' (RHI), and Nancy Histological Index (NHI). A convolutional neural network classifier was trained to distinguish remission from activity on a subset of 118 biopsies, calibrated on 42 and tested on 375. The model was additionally tested to predict the corresponding endoscopic assessment and occurrence of flares at 12 months. The system output was compared with human assessment. Diagnostic performance was reported as sensitivity, specificity; prognostic prediction through Kaplan-Meier and hazard ratios of flares between active and remission groups. We externally validated the model in 154 biopsies (58 patients) with similar characteristics but more histologically active patients. Results: The system distinguished histological activity/remission with sensitivity and specificity of 89% and 85% (PHRI), 94% and 76% (RHI), and 89% and 79% (NHI). The model predicted the corresponding endoscopic remission/activity with 79% and 82% accuracy for UCEIS and PICaSSO, respectively. The hazard ratio for disease flare-up between histological activity/remission groups according to pathologist-assessed PHRI was 3.56, and 4.64 for AI-assessed PHRI. Both histology and outcome prediction were confirmed in the external validation cohort. Conclusion: We developed and validated an AI model that distinguishes histological remission/activity in biopsies of UC and predicts flare-ups. This can expedite, standardize and enhance histological assessment in practice and trials.
Computer-aided diagnosis; Convolutional Neural Network; Picasso Histologic Remission Index; Robarts Histopathology index; Ulcerative Colitis
Settore MED/12 - Gastroenterologia
2023
4-mar-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS0016508523002160.pdf

Open Access dal 05/03/2024

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 14.92 MB
Formato Adobe PDF
14.92 MB Adobe PDF Visualizza/Apri
1-s2.0-S0016508523002160-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.15 MB
Formato Adobe PDF
2.15 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/962515
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 9
social impact